Jenburkt Pharmaceuticals has informed that the meeting of the Board of Directors of the Company is scheduled on 07/02/2020 to consider and approve unaudited financial results of the Company for the quarter and nine months ended on 31st December, 2019.
The above information is a part of company’s filings submitted to BSE.